Age Range
Izinsuku ezingama-29 - Iminyaka engu-17 (Ingane)
Trial Purpose
Lolu cwaningo luhlose ukuqhathanisa ukusebenza kahle kwe-vericiguat ne-placebo ekushintsheni kwe-n-terminal pro-brain natriuretic peptide (NTproBNP) kusukela kwesisekelo kuya Iviki 16 Lenkathi Eyisisekelo. I-hypothesis eyinhloko iwukuthi i-vericiguat iphakeme kune-placebo ekwehliseni i-NT-proBNP Evikini 16 Lesikhathi Esiyisisekelo.
NATIONAL TRIAL REFERENCE NUMBER
I-NCT05714085
EudraCT
2021-004399-33
EU CT Number
2022-501238-52-00
When speaking to your doctor or clinical trial representative, please have the trial reference number available.
About The Study
Trial Phase
Trial start and end dates
- Actual study start date Meyi 31, 2023
- Estimated primary completion date Ephreli 15, 2032
- Estimated study completion date Ephreli 15, 2032